Thermo Fisher Scientific is investing $50 million in its St. Louis, MO site, one of the company’s Centers of Excellence for biologic commercial manufacturing. The investment is part of the company’s expansion strategy for its global network of biologic drug substance capabilities for clinical and commercial supply. The project includes expansion of the existing manufacturing building with an additional 64,000 sq.-ft., which will double manufacturing capacity and will be operational in 2...